Bausch Health Companies Inc. (TSX:BHC)
6.69
+0.31 (4.86%)
May 12, 2025, 4:00 PM EDT
Bausch Health Companies Revenue
Bausch Health Companies had revenue of $2.26B USD in the quarter ending March 31, 2025, with 4.92% growth. This brings the company's revenue in the last twelve months to $9.73B, up 8.53% year-over-year. In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth.
Revenue (ttm)
$9.73B
Revenue Growth
+8.53%
P/S Ratio
0.18
Revenue / Employee
$470.10K
Employees
20,700
Market Cap
2.47B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 896.45M |
Extendicare | 1.47B |
Trulieve Cannabis | 1.71B |
Cronos Group | 179.08M |
WELL Health Technologies | 919.69M |
Curaleaf Holdings | 1.89B |
Bausch Health Companies News
- 3 days ago - Bill Ackman Took A $4 Billion Hit But Says 'Making Progress Each Day' Was Key To Recovering From The Valeant Disaster - Benzinga
- 5 days ago - Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens - Business Wire
- 6 days ago - Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization - Accesswire
- 12 days ago - Bausch health outlines 2025 guidance with 4-5% revenue and EBITDA growth amid strategic refinancing - Seeking Alpha
- 12 days ago - Bausch Health Companies Inc. (BHC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Bausch Health Companies Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 12 days ago - Bausch Health Announces First Quarter 2025 Results - Accesswire
- 13 days ago - Bausch Health Companies Q1 2025 Earnings Preview - Seeking Alpha